I am a
Home I AM A Search Login

Papers of the Week

2022 Feb 08

J Vasc Access

Surgical management after Oxaliplatin extravasation: A case report and literature review.


Van Praet L, Boecxstaens V, Douchy T
J Vasc Access. 2022 Feb 08:11297298221075237.
PMID: 35130786.


This case report describes a unique case of chronic reaction after extravasation of oxaliplatin. The pain and extensive subcutaneous induration did not resolve after 9 months of conservative treatment. Surgical debridement with removal of the totally implantable venous access device (TIVAD) resulted in immediate resolution of the symptoms. Oxaliplatin has both irritant and vesicant properties that are difficult to distinguish at initial clinical presentation. In most literature cases complaints resolve within 3 months with conservative treatment yet surgical debridement should be considered if complaints persist beyond this period.